DeepMed Research

Vall d'Hebron Research Institute

🇪🇸Spain

Country: 🇪🇸Spain

Ownership: Private

Established: 1994-01-01

Employees: 1K

Market Cap: -

Website: http://www.vhir.org

Clinical Trials

Low Weight Heparin prOphylaxis for Placental-Mediated Complications of PrEgnancy

Phase 3

Completed

Conditions: Placental Insufficiency
High Risk Pregnant Women
Preeclampsia

Interventions: Drug: Enoxaparin

First Posted Date: 2011-07-06

Last Posted Date: 2016-12-21

Lead Sponsor: Hospital Universitari Vall d'Hebron Research Institute

Target Recruit Count: 361

Registration Number: NCT01388322

Locations: 🇪🇸
Hospital de Cruces, Barakaldo, Vizcaya, Spain
🇪🇸
Hospital Universitario Vall d'Hebron, Barcelona, Spain
🇪🇸
Hospital Sant Joan de Deu, Esplugues de Llobregat, Barcelona, Spain

and more 1 locations

Platelet-rich Plasma Intra-articular Knee Injections for Knee Osteoarthritis

Phase 3

Completed

Conditions: Knee Osteoarthritis

Interventions: Biological: platelet-rich plasma
Drug: Corticosteroid

First Posted Date: 2011-06-27

Last Posted Date: 2015-02-24

Lead Sponsor: Hospital Universitari Vall d'Hebron Research Institute

Target Recruit Count: 74

Registration Number: NCT01381081

Locations: 🇪🇸
Hospital Universitario Vall d'Hebron, Barcelona, Spain

The Trial of Pessary After Laser for TTTS

Not Applicable

Terminated

Conditions: Premature Birth

Interventions: Device: Arabin Cervical Pessary

First Posted Date: 2011-04-13

Last Posted Date: 2020-08-27

Lead Sponsor: Hospital Universitari Vall d'Hebron Research Institute

Target Recruit Count: 352

Registration Number: NCT01334489

Locations: 🇪🇸
Hospital Universitari Vall d'Hebron, Barcelona, Spain
🇩🇪
University Medical Center Eppendorf, Hamburg, Germany
🇧🇪
UZ Leuven. Campus Gasthuisberg, Leuven, Belgium

and more 1 locations

Effect of Diet on Intestinal Gas Production and Evacuation in Healthy Subjects and Flatulent Patients

Not Applicable

Completed

Conditions: Flatulence

Interventions: Dietary Supplement: High flatulogenic diet

First Posted Date: 2011-02-08

Last Posted Date: 2012-03-23

Lead Sponsor: Hospital Universitari Vall d'Hebron Research Institute

Target Recruit Count: 50

Registration Number: NCT01291446

Locations: 🇪🇸
University Hospital Vall d'Hebron, Barcelona, Spain

Study Assessing Safety and Efficiency of the Lenalidomide and Dexamethasone Combination in Patients With Chronic Lymphatic Leukemia (CLL) Relapsing or Resistant to Treatment

Phase 1

Completed

Conditions: Chronic Lymphatic Leukemia

First Posted Date: 2010-11-23

Last Posted Date: 2014-04-04

Lead Sponsor: Hospital Universitari Vall d'Hebron Research Institute

Target Recruit Count: 20

Registration Number: NCT01246557

Locations: 🇪🇸
Centro Médico Teknon, Barcelona, Spain
🇪🇸
Hospital Universitari Valle Hebron, Barcelona, Spain
🇪🇸
Hospital Clínico Universitario de Valencia, Valencia, Spain

and more 3 locations

Efficacy and Security of Intrapleurally Alteplase vs Urokinase for the Treatment of Complicated Parapneumonic Effusion and Empyema

Phase 4

Completed

Conditions: Empyema, Pleural
Pleural Effusion
Pleural Diseases

Interventions: Drug: Intrapleurally Alteplase vs Intrapleurally Urokinase

First Posted Date: 2010-11-23

Last Posted Date: 2011-07-18

Lead Sponsor: Hospital Universitari Vall d'Hebron Research Institute

Target Recruit Count: 204

Registration Number: NCT01246453

Locations: 🇪🇸
Hospital Vall d'Hebron, Barcelona, Catalunya, Spain
🇪🇸
Hospital Arnau de Vilanova, LLeida, Catalunya, Spain

Treatment of Abdominal Distension by Biofeedback - a Randomized Controlled Trial

Not Applicable

Completed

Conditions: Dyspepsia
Irritable Bowel Syndrome

Interventions: Drug: Placebo
Behavioral: Bio-feedback

First Posted Date: 2010-09-20

Last Posted Date: 2016-07-27

Lead Sponsor: Hospital Universitari Vall d'Hebron Research Institute

Target Recruit Count: 48

Registration Number: NCT01205100

Locations: 🇪🇸
University Hospital Vall d'Hebron, Barcelona, Catalunya, Spain

Study of Sleep Habits and Prevalence of Sleepiness in a Health Care Environment in Barcelona

Completed

Conditions: Sleep
Subjective Sleepiness
Sleep Apnea

First Posted Date: 2010-08-04

Last Posted Date: 2011-07-06

Lead Sponsor: Hospital Universitari Vall d'Hebron Research Institute

Target Recruit Count: 500

Registration Number: NCT01175304

Locations: 🇪🇸
Hospital Universitari Vall D' Hebron, Barcelona, Spain

Clinical Trial For The Treatment Of Chronic Chagas Disease With Posaconazole And Benznidazole

Phase 2

Completed

Conditions: Chagas Disease

Interventions: Drug: Posaconazole
Drug: Benznidazole

First Posted Date: 2010-07-15

Last Posted Date: 2013-09-10

Lead Sponsor: Hospital Universitari Vall d'Hebron Research Institute

Target Recruit Count: 78

Registration Number: NCT01162967

Locations: 🇪🇸
International Health Unit Drassanes, Barcelona, Spain
🇪🇸
Infectious Disease Department Vall d'Hebron Hospital, Barcelona, Spain
🇪🇸
International Health Unit Metropolitana Nord, Santa Coloma, Barcelona, Spain

Anticoagulation in Stent Intervention

Phase 4

Conditions: Atrial Fibrillation
Stroke

Interventions: Drug: Acetylsalicylic Acid + clopidogrel + acenocoumarol
Drug: Acetylsalicylic Acid + clopidogrel

First Posted Date: 2010-06-10

Last Posted Date: 2015-02-24

Lead Sponsor: Hospital Universitari Vall d'Hebron Research Institute

Target Recruit Count: 304

Registration Number: NCT01141153

Locations: 🇪🇸
Hospital Germans Trias i Pujol, Badalona, Barcelona, Spain
🇪🇸
Hospital Sant Pau, Barcelona, Spain
🇪🇸
Hospital Universitari de Bellvitge, Hospitalet de Llobregat, Barcelona, Spain

and more 8 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy